中文版 | English
题名

Gallic acid disruption of A beta(1-42) aggregation rescues cognitive decline of APP/PS1 double transgenic mouse

作者
通讯作者Hou, Sheng-Tao
发表日期
2019-04
DOI
发表期刊
ISSN
0969-9961
EISSN
1095-953X
卷号124页码:67-80
摘要

Alzheimer's disease (AD) treatment represents one of the largest unmet medical needs. Developing small molecules targeting A beta aggregation is an effective approach to prevent and treat AD. Here, we show that gallic acid (GA), a naturally occurring polyphenolic small molecule rich in grape seeds and fruits, has the capacity to alleviate cognitive decline of APP/PS1 transgenic mouse through reduction of A beta(1-42) aggregation and neurotoxicity. Oral administration of GA not only improved the spatial reference memory and spatial working memory of 4-month-old APP/PS1 mice, but also significantly reduced the more severe deficits developed in the 9-month-old APP/PS1 mice in terms of spatial learning, reference memory, short-term recognition and spatial working memory. The hippocampal long-term-potentiation (LTP) was also significantly elevated in the GA-treated 9-month-old APP/PS1 mice with increased expression of synaptic marker proteins. Evidence from atomic force microscopy (AFM), dynamic light scattering (DLS) and thioflavin T (ThT) fluorescence densitometry analyses showed that GA significantly reduces A beta(1-42) aggregation both in vitro and in vivo. Further, pre-incubating GA with oligomeric A beta(1-42) reduced A beta(1-42)-mediated intracellular calcium influx and neurotoxicity. Molecular docking studies identified that the 3,4,5-hydroxyle groups of GA were essential in noncovalently stabilizing GA binding to the Lys28-Ala42 salt bridge and the -COOH group is critical for disrupting the salt bridge of A beta(1-42). The predicated covalent interaction through Schiff-base formation between the carbonyl group of the oxidized product and epsilon-amino group of Lys16 is also critical for the disruption of A beta(1-42) S-shaped triple-beta-motif and toxicity. Together, these studies demonstrated that GA can be further developed as a drug to treat AD through disrupting the formation of A beta(1-42) aggregation.

关键词
相关链接[来源记录]
收录类别
语种
英语
学校署名
第一 ; 通讯
资助项目
SZDRC[K16205905]
WOS研究方向
Neurosciences & Neurology
WOS类目
Neurosciences
WOS记录号
WOS:000459217800007
出版者
ESI学科分类
NEUROSCIENCE & BEHAVIOR
来源库
Web of Science
引用统计
被引频次[WOS]:86
成果类型期刊论文
条目标识符http://sustech.caswiz.com/handle/2SGJ60CL/26159
专题生命科学学院_生物系
理学院_化学系
作者单位
1.Southern Univ Sci & Technol, Brain Res Ctr, 1088 Xueyuan Blvd, Shenzhen 518055, Guangdong, Peoples R China
2.Southern Univ Sci & Technol, Dept Biol, 1088 Xueyuan Blvd, Shenzhen 518055, Guangdong, Peoples R China
3.Southern Med Univ, Key Lab Psychiat Disorders Guangdong Prov, Guangzhou 510515, Guangdong, Peoples R China
4.Southern Univ Sci & Technol, Dept Chem, 1088 Xueyuan Blvd, Shenzhen 518055, Guangdong, Peoples R China
第一作者单位南方科技大学;  生物系
通讯作者单位南方科技大学;  生物系
第一作者的第一单位南方科技大学
推荐引用方式
GB/T 7714
Yu, Mei,Chen, Xuwei,Liu, Jihong,et al. Gallic acid disruption of A beta(1-42) aggregation rescues cognitive decline of APP/PS1 double transgenic mouse[J]. NEUROBIOLOGY OF DISEASE,2019,124:67-80.
APA
Yu, Mei.,Chen, Xuwei.,Liu, Jihong.,Ma, Quan.,Zhuo, Zhan.,...&Hou, Sheng-Tao.(2019).Gallic acid disruption of A beta(1-42) aggregation rescues cognitive decline of APP/PS1 double transgenic mouse.NEUROBIOLOGY OF DISEASE,124,67-80.
MLA
Yu, Mei,et al."Gallic acid disruption of A beta(1-42) aggregation rescues cognitive decline of APP/PS1 double transgenic mouse".NEUROBIOLOGY OF DISEASE 124(2019):67-80.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可 操作
Gallic acid disrupti(3757KB)----限制开放--
个性服务
原文链接
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
导出为Excel格式
导出为Csv格式
Altmetrics Score
谷歌学术
谷歌学术中相似的文章
[Yu, Mei]的文章
[Chen, Xuwei]的文章
[Liu, Jihong]的文章
百度学术
百度学术中相似的文章
[Yu, Mei]的文章
[Chen, Xuwei]的文章
[Liu, Jihong]的文章
必应学术
必应学术中相似的文章
[Yu, Mei]的文章
[Chen, Xuwei]的文章
[Liu, Jihong]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
[发表评论/异议/意见]
暂无评论

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。